Pharmacokinetic Interaction Study of Dapoxetine 30mg and Mirodenafil 50mg
Phase 1
Completed
- Conditions
- Interventions
- First Posted Date
- 2015-06-30
- Last Posted Date
- 2015-06-30
- Lead Sponsor
- SK Chemicals Co., Ltd.
- Target Recruit Count
- 36
- Registration Number
- NCT02485028
Pharmacokinetic Interaction Study of Dapoxetine 30mg and Mirodenafil 100mg
Phase 1
Completed
- Conditions
- Interventions
- First Posted Date
- 2015-06-30
- Last Posted Date
- 2015-06-30
- Lead Sponsor
- SK Chemicals Co., Ltd.
- Target Recruit Count
- 36
- Registration Number
- NCT02485041
Clinical Study to Assess the Efficacy and Safety of THVD-201 in Patients With OAB
Phase 3
Completed
- Conditions
- Interventions
- First Posted Date
- 2015-06-30
- Last Posted Date
- 2017-01-12
- Lead Sponsor
- SK Chemicals Co., Ltd.
- Target Recruit Count
- 384
- Registration Number
- NCT02485067
- Locations
- 🇰🇷
Asan Medical Center, Seoul, Korea, Republic of
🇰🇷The Catholic University of Korea, Bucheon ST. Mary's Hospital, Seoul, Korea, Republic of
🇰🇷Severance Hospital, Seoul, Korea, Republic of
Immunogenicity and Safety of Quadrivalent Influenza Vaccine (NBP607-QIV) in Adults and Elderly Subjects
Phase 3
Completed
- Conditions
- Interventions
- First Posted Date
- 2015-06-10
- Last Posted Date
- 2020-05-08
- Lead Sponsor
- SK Chemicals Co., Ltd.
- Target Recruit Count
- 1503
- Registration Number
- NCT02467842
Study of Egg-derived Influenza Vaccine and Cell Culture-derived Influenza Vaccine in Adult and Elderly Subjects
- First Posted Date
- 2015-01-22
- Last Posted Date
- 2015-01-22
- Lead Sponsor
- SK Chemicals Co., Ltd.
- Target Recruit Count
- 1155
- Registration Number
- NCT02344134
Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Study of SKI2670
- First Posted Date
- 2014-07-29
- Last Posted Date
- 2017-10-20
- Lead Sponsor
- SK Chemicals Co., Ltd.
- Target Recruit Count
- 16
- Registration Number
- NCT02202408
- Locations
- 🇰🇷
Asan Medical Center, Seoul, Korea, Republic of
Immunogenicity and Safety Study of NBP606 in Healthy Infants
Phase 3
Completed
- Conditions
- Interventions
- First Posted Date
- 2014-07-25
- Last Posted Date
- 2020-04-20
- Lead Sponsor
- SK Chemicals Co., Ltd.
- Target Recruit Count
- 577
- Registration Number
- NCT02201030
- Locations
- 🇰🇷
Confidential, Seoul, Korea, Republic of
Efficacy and Safety of YKP10811 in Subjects With Irritable Bowel Syndrome With Constipation
Phase 2
Completed
- Conditions
- Interventions
- First Posted Date
- 2014-03-10
- Last Posted Date
- 2015-06-12
- Lead Sponsor
- SK Chemicals Co., Ltd.
- Target Recruit Count
- 273
- Registration Number
- NCT02082457
- Locations
- 🇰🇷
Gang Nam Severance Hospital, Gang Nam Gu, Seoul, Korea, Republic of
Study to Assess the Efficacy and Safety of SKI3246 in Subjects With Non-Constipation Irritable Bowel Syndrome
Phase 2
Completed
- Conditions
- Interventions
- First Posted Date
- 2014-03-06
- Last Posted Date
- 2015-06-01
- Lead Sponsor
- SK Chemicals Co., Ltd.
- Target Recruit Count
- 279
- Registration Number
- NCT02079675
- Locations
- 🇰🇷
SK Chemicals, Seoul, Korea, Republic of
Study Immunogenicity and Safety of 13-valent Pneumococcal Conjugate Vaccine
Phase 3
Completed
- Conditions
- Interventions
- First Posted Date
- 2014-03-05
- Last Posted Date
- 2016-01-27
- Lead Sponsor
- SK Chemicals Co., Ltd.
- Target Recruit Count
- 767
- Registration Number
- NCT02079207
© Copyright 2024. All Rights Reserved by MedPath